New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
08:31 EDTBPTHBio-Path Holdings names Ulrich Mueller as COO
Bio-Path Holdings announced that Dr. Ulrich W. Mueller has joined the company as COO. Dr. Mueller will be responsible for the company’s drug development, licensing and intellectual property activities, including managing the company’s clinical trials, pre-clinical and research and development efforts. Mueller was previously a Vice President at the Fred Hutchinson Center Research Center.
News For BPTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 17, 2015
08:36 EDTBPTHBio-Path Holdings reports FY14 EPS (5c), one estimate (4c)
Reports FY14 net loss ($4.5M), primarily due to an increase of approximately $1.1M in general and administrative expense. Reports operating expenses increased by $1.3M to $4.5M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use